Community-acquired Pneumonia in People With Human Immunodeficiency Virus (HIV) During the Current Era of Effective Antiretroviral Therapy: A Multicenter Retrospective Cohort Study

被引:0
|
作者
Bai, Anthony D. [1 ]
Srivastava, Siddhartha [2 ]
Cajas, Jorge L. Martinez [1 ]
Razak, Fahad [3 ,4 ,5 ]
Verma, Amol A. [3 ,4 ,5 ]
机构
[1] Queens Univ, Dept Med, Div Infect Dis, Etherington Hall Room 3010,94 Stuart St, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Med, Div Gen Internal Med, Kingston, ON, Canada
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] St Michaels Hosp, Li Ka Shing Knowledge Inst, Unity Hlth Toronto, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
human immunodeficiency virus (HIV); AIDS; community-acquired pneumonia; mortality; cohort study; HOSPITALIZED-PATIENTS; SCORE; EPIDEMIOLOGY; INFECTION; SEVERITY; ETIOLOGY; ADULTS;
D O I
10.1093/cid/ciae393
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background It is unclear if human immunodeficiency virus (HIV) affects the prognosis for community-acquired pneumonia (CAP) in the current era of effective antiretroviral therapy. In this multicenter retrospective cohort study of patients admitted for CAP, we compared the in-hospital mortality rate between people with HIV (PWH) and those without.Methods The study included consecutive patients admitted with a diagnosis of CAP across 31 hospitals in Ontario, Canada, from 2015 to 2022. HIV infection was based on discharge diagnoses and antiretroviral prescription. The primary outcome was in-hospital mortality. Competing risk models were used to describe time to death in hospital or discharge. Potential confounders were balanced using overlap weighting of propensity scores.Results Of 82 822 patients admitted with CAP, 1518 (1.8%) had a diagnosis of HIV. PWH were more likely to be younger, male, and have fewer comorbidities. In the hospital, 67 (4.4%) PWH and 6873 (8.5%) people without HIV died. HIV status had an adjusted subdistribution hazard ratio of 1.02 (95% confidence interval, .80-1.31; P = .8440) for dying in the hospital. Of 1518 PWH, 440 (29.0%) patients had a diagnosis of AIDS. AIDS diagnosis had an adjusted subdistribution hazard ratio of 3.04 (95% CI, 1.69-5.45; P = .0002) for dying in the hospital compared to HIV without AIDS.Conclusions People with and without HIV admitted for CAP had a similar in-hospital mortality rate. For PWH, AIDS significantly increased the mortality risk. HIV infection by itself without AIDS should not be considered a poor prognostic factor for CAP. In this large multicenter retrospective cohort study, HIV status by itself was not a risk factor for in-hospital mortality in community-acquired pneumonia. People with HIV who did not have AIDS had a significantly lower mortality risk than people with AIDS. Graphical abstract This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/community-acquired-pneumonia-in-people-with-human-immunodeficiency-virus-hiv-during-the-current-era-of-effective-antiretroviral-therapy-a-multi-center-retrospective-cohort-study?utm_campaign=tidbitlinkshare&utm_source=IO
引用
收藏
页码:397 / 403
页数:7
相关论文
共 50 条
  • [1] HIV-associated community-acquired pneumonia in the highly active antiretroviral therapy era
    Viale, P
    Scudeller, L
    Signorini, L
    Cadeo, B
    Petrosillo, N
    Pagani, L
    Carosi, G
    AIDS, 2002, 16 (17) : 2361 - 2362
  • [2] Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy
    Van Epps, Puja
    Kalayjian, Robert C.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2017, 31 (04) : 791 - +
  • [3] The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
    Jensen, Andreas Vestergaard
    Baunbaek-Knudsen, Gertrud
    Andersen, Stine Bang
    Petersen, Pelle Trier
    Benfield, Thomas
    Faurholt-Jepsen, Daniel
    Rohde, Gernot
    Ravn, Pernille
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [4] Community-acquired pneumonia in human immunodeficiency virus-infected patients
    Cunha, BA
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) : 410 - 411
  • [5] Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: A multicenter retrospective cohort study
    Komiya, Kosaku
    Ishii, Hiroshi
    Umeki, Kenji
    Mizunoe, Shunji
    Okada, Fumito
    Johkoh, Takeshi
    Kadota, Jun-ichi
    RESPIROLOGY, 2013, 18 (03) : 514 - 521
  • [6] Community-acquired Klebsiella pneumoniae pneumonia in ICU: a multicenter retrospective study
    Grosjean, Vincent
    Gressens, Simon B.
    Pham, Tai
    Gaudry, Stephane
    Ait-Oufella, Hafid
    De Prost, Nicolas
    Mayaux, Julien
    Guerot, Emmanuel
    Leflon-Guibout, Veronique
    Mayer, Noemie
    Bert, Frederic
    Gault, Nathalie
    Massonnaud, Clement R.
    Roux, Damien
    ANNALS OF INTENSIVE CARE, 2024, 14 (01)
  • [7] Bacteremia Prediction Model for Community-acquired Pneumonia: External Validation in a Multicenter Retrospective Cohort
    Kim, Byunghyun
    Choi, Jungho
    Kim, Kyuseok
    Jang, Sujin
    Shin, Tae Gun
    Kim, Won Young
    Kim, Jung-Youn
    Park, Yoo Seok
    Kim, Soo Hyun
    Lee, Hui Jai
    Shin, Jonghwan
    You, Je Sung
    Kim, Kyung Su
    Chung, Sung Phil
    ACADEMIC EMERGENCY MEDICINE, 2017, 24 (10) : 1226 - 1234
  • [8] Identifying subgroup of severe community-acquired pneumonia based on clinical metagenomics, a multicenter retrospective cohort study
    Wang, Mingqiang
    Jin, Yue
    Zhang, Wenxiao
    Ye, Ling
    Shao, Huanzhang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2025, 14
  • [9] Community-acquired pneumonia in human immunodeficiency virus-infected patients - Reply
    Baril, L
    Schneider, L
    Astagneau, P
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) : 411 - 412
  • [10] Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study
    Pauline Guillot
    Flora Delamaire
    Arnaud Gacouin
    Benoit Painvin
    Caroline Piau
    Florian Reizine
    Mathieu Lesouhaitier
    Jean-Marc Tadié
    Adel Maamar
    BMC Infectious Diseases, 23